{
  "id": 16815113,
  "title": "$10,000 Invested in Eli Lilly 5 Years Ago Would Be Worth This Much Today",
  "url": "https://urgent.news/2026/10/27/10-000-invested-in-eli-lilly-5-years-ago-would-be-worth-this-much",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-27T23:08:00.000Z",
  "source": {
    "name": "Motley Fool",
    "slug": "motley-fool",
    "url": "https://www.fool.com/investing/2026/10/27/10000-invested-in-eli-lilly-5-years-ago-would-be-w/?source=iedfolrf0000001"
  },
  "original_language": "en",
  "account": "If you had invested $10,000 in Eli Lilly five years ago, your investment would be worth approximately $54,477 today, thanks to the company's remarkable average annual return of 40.36%. This return dwarfs the performance of an S&P 500 ETF, which would have resulted in a $17,940 portfolio value over the same period. The pharmaceutical giant has solidified its position as a leader in the rapidly expanding GLP-1 market, with its top-selling drugs posting impressive sales growth. Furthermore, Eli Lilly boasts an extensive pipeline in its core therapeutic area, which ranks among the best in the industry. The company also possesses a diverse portfolio of other therapeutic areas, potentially leading to significant advancements in the coming years. Despite intense competition in the GLP-1 sector, Eli Lilly's outlook remains promising, and it appears well-equipped to outperform the broader market.",
  "summary": "The company has made longtime shareholders much richer.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Nasdaq Markets",
        "title": "$10,000 Invested in Eli Lilly 5 Years Ago Would Be Worth This Much Today",
        "url": "https://urgent.news/2026/10/27/10-000-invested-in-eli-lilly-5-years-ago-would-be-worth-this-much-16823496",
        "published": "2026-10-27T23:28:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}